MedICAL ADVOCATES
Children
  Opportunistic Diseases
 
Guidelines
General Reports
 OI Drugs: General
Aspergillosis 
 Candidiasis              
Coccidioidomycosis
 Cryptococcosis
Cryptosporidiosis
CMV
Histoplasmosis
 		 Kaposi's Sarcoma
Microsporidiosis
M. avium complex 
 Penicilliosis  
PCP
 Toxoplasmosis 




 





 
Pediatric Disease Index Main New and Noteworthy Home Page
Last Update:  June 11, 2008      
  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Prevention/Treatment Guidelines
       

     Journal Papers, Abstracts, and Commentaries     

  FULL-TEXT ARTICLE
Treating opportunistic infections among HIV-exposed and infected children:
recommendations from CDC, the National Institutes of Health, and the Infectious
Diseases Society of America.
Mofenson LM, Oleske J, Serchuck L, et al
MMWR Dec 3, 2004 / 53(RR14);1-63
 Paper		  
General Reports
       

          Journal Papers, Abstracts, and Commentaries     

 
Trends in Opportunistic Infections in the Pre-and Post-Highly Active Antiretroviral Therapy Eras
Among HIV-Infected Children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
 Nesheim SR, Kapogiannis BG, Soe MM, et al 
Pediatrics. 2007 Jul;120(1):100-9
 Abstract
 
Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the
era of highly active antiretroviral therapy.
Ylitalo N, Brogly S, Hughes MD, Nachman S, et al 
Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.
Abstract
 
Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P, Van Dyke RB, Williams PL, et al; J
AMA. 2006 Jul 19;296(3):292-300.
Abstract
 
The Rate of Serious Bacterial Infections Among HIV-Infected Children With Immune
Reconstitution Who Have Discontinued Opportunistic Infection Prophylaxis.
Nachman S, Gona P, Dankner W, et al 
Pediatrics. 2005 Mar 16;
Abstract

Correlates of opportunistic infections in children infected with the human
immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM, Lindsey JC, Levin MJ;
Pediatr Infect Dis J 2001 Jan;20(1):40-8
Abstract
 

  

           Conference Reports, Abstracts, and Posters 

  CONFERENCE PDF POSTER
An Observational Study of the Rate of Opportunistic Infections Events in HIV-
infected Children Who Have Demonstrated Immunologic Reconstitution and
Who Have Discontinued Prophylaxis
W Dankner, S Nachman, W Hughes, et al
 (11 CROI)
 PDF Poster       Abstract
OI Drugs: General
       
Cotrimoxazole       

          Conference Reports, Abstracts, and Posters 
 
  A Randomized Placebo-controlled Trial of Cotrimoxazole as Prophylaxis against
Opportunistic Infections in Children with HIV-1 Infection in Zambia
V Mulenga, D Gibb, G Bhat, et al
 (11 CROI)
 Abstract
 

Trimethoprim-Sulfamethoxazole

          Journal Papers, Abstracts, and Commentaries     

 
Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.
Zar HJ, Langdon G, Apolles P, et al
S Afr Med J. 2006 Jul;96(7):627-9.
 Abstract

Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with
 MHC class II deficiency: diazoxide as a treatment option.
Gonc EN, Turul T, Yordam N, Ersoy F.
J Pediatr Endocrinol Metab. 2003 Dec;16(9):1307-9
Abstract

Pediatric Disease Index Main New and Noteworthy Home Page

Photo by Caroline Jacoby Courtesy of M/MC Photoshare at www.jhuccp.org/mmc  and is protected by current copyright law 
Pediatric Internet Resource Center
Opportunistic Infections Index